Targeting extracellular inflammatory mediators or intracellular pathways for dermatological diseases: Which is better?
Amphitheatre A
Date: Friday 20 September 2019, 13.00-14.30
Room: Amphitheatre A
Chairperson: Prof. Errol Prens (Rotterdam, The Netherlands)
Overarching symposium objectives:
For psoriasis, atopic dermatitis and hidradenitis suppurativa:
1. Provide an overview of agents which target extracellular inflammatory mediators and intracellular pathways.
2. Critically evaluate extracellular and intracellular therapeutic approaches.
3. Identify areas of clinical research that are needed to advance our treatment and understanding
Program
| 13.00-13.05 | Opening statement Errol Prens (Rotterdam, The Netherlands)
|
| 13.05-13.25 | Focus on: Psoriasis Curdin Conrad (Lausanne, Switzerland)
|
| 13.25-13.30 | Audience Q&A
|
| 13.30-13.50 | Focus on: Atopic dermatitis Nick Reynolds (Newcastle upon Tyne, UK)
|
| 13.50-13.55 | Audience Q&A
|
| 13.55-14.15 | Focus on: Hidradenitis suppurativa Errol Prens (Rotterdam, The Netherlands)
|
| 14.15-14.20 | Audience Q&A
|
| 14.20-14.30 | Closing Statement Errol Prens (Rotterdam, The Netherlands) |
Sponsored Symposium